![Terry Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 204 329 $ in data 31/07/2026
Terry Evans currently works at Fennec Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Mr. Evans also formerly worked at Unite Pharma Trade Advisors, as Chief Executive Officer and Currax Pharmaceuticals LLC, as Chief Operating Officer.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/08/2026 | 21.351 ( 0,06% ) | 204 329 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Corporate Officer/Principal | 28/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
Currax Pharmaceuticals LLC
 Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
